Hello FPC forum,
So after messaging with Soumen79, I realized that this was overdue...
Over the last few years, I posted a series of articles on prostate cancer vaccine candidates, what I felt was their potential, and relevant information from clinical data. I thought it might be time to give an update and see what has happened in 1 year.
Let's begin with RV001, which I felt had great potential for PCa sufferers. Rhovac has now completed Phase IIb, and the study evaluated this treatment in more than 175 patients and released data. The data was not favorable:
fiercebiotech.com/biotech/r...
Next, I posted on Advaxis, a company with 2 PCa vaccine candidates-- ADXS-PSA and ADXS-504 ( a neoantigen vaccine-off the shelf).:
At this point, ADXS-PSA has not yet announced Phase III trial despite positive phase II results. There is an announcement of the initial Phase I trial results for ADXS-504 as below:
advaxis.com/news-releases/n...
I think that an off the shelf vaccine sequenced properly with other therapies might have a real show stopping effect on PCa.
Next, my post on the 2 vaccine brothers being done at University of Wisconsin:
healthunlocked.com/fight-pr...
and the trial itself:
clinicaltrials.gov/ct2/show...
The estimated primary completion date is pushed back into 2023. For those that have MCRPC, this trial is open enrollment for 60 volunteers initially. Locations are in Wisconsin and Missouri...
Lastly, there is the new kid on the block.. OVM-200. This has been posted on by Brysonal on this forum:
healthunlocked.com/fight-pr...
Some more info:
dailymail.co.uk/health/arti...
Treatment alternatives continue to evolve as The Science is Coming !!
C'mon Mother Science and Father Christmas....
Don Pescado